Capitalizing On The GI M&A Market, With Sap Sinha (Podcast) (The Corner Series)

At Allied Digestive Health, a rapidly expanding gastroenterology group with 194 GI physicians and 75 nurse practitioners across New Jersey and New York, COO Sap Sinha shares an optimistic outlook on the future. “Private equity is focusing heavily on GI for several reasons,” Sinha explains in a discussion with host Geoff Cockrell, highlighting that colon cancer remains the second leading cause of cancer-related deaths in the U.S. Sinha also outlines Allied’s current focus on investing in clinical quality, collaborating with major institutions, and advancing frontiers like genetic testing for colon cancer detection and weight management solutions to address non-alcoholic fatty liver disease.